CINECA IRIS Institutional Research Information System

FORNI, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.458
EU - Europa 4.613
AS - Asia 1.575
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 3
Totale 11.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.321
CN - Cina 996
UA - Ucraina 658
IT - Italia 644
IE - Irlanda 594
SE - Svezia 583
DE - Germania 510
FR - Francia 486
FI - Finlandia 399
KR - Corea 363
GB - Regno Unito 251
PL - Polonia 149
CA - Canada 135
DK - Danimarca 123
AT - Austria 121
VN - Vietnam 107
SN - Senegal 65
IN - India 36
BE - Belgio 24
NL - Olanda 19
SG - Singapore 14
RU - Federazione Russa 13
CH - Svizzera 9
IL - Israele 9
TW - Taiwan 9
UZ - Uzbekistan 9
GR - Grecia 8
HK - Hong Kong 7
IR - Iran 7
MU - Mauritius 7
AU - Australia 5
ES - Italia 5
EU - Europa 5
JP - Giappone 5
ZA - Sudafrica 5
PH - Filippine 4
PT - Portogallo 4
BG - Bulgaria 3
RO - Romania 3
SA - Arabia Saudita 3
AR - Argentina 2
BY - Bielorussia 2
HU - Ungheria 2
LT - Lituania 2
MX - Messico 2
TH - Thailandia 2
BH - Bahrain 1
BR - Brasile 1
CZ - Repubblica Ceca 1
LB - Libano 1
MY - Malesia 1
PK - Pakistan 1
Totale 11.736
Salva come PNG Salva come JPEG
Città #
Chandler 940
Beijing 829
Dublin 594
Jacksonville 429
Ann Arbor 362
Villeurbanne 327
Houston 319
Medford 232
Princeton 222
Ashburn 210
Dearborn 183
Nyköping 178
Wilmington 154
Warsaw 148
Torino 123
Vienna 117
Milan 93
Fremont 81
Fairfield 79
Toronto 78
Boston 72
Dong Ket 66
Woodbridge 63
Verona 54
Boardman 53
Pisa 38
Seattle 38
Falls Church 32
New York 29
Cambridge 28
Norwalk 28
Rome 28
Turin 26
Lachine 25
Hefei 24
Ottawa 24
Pune 23
Washington 23
Brussels 22
Düsseldorf 21
Nanjing 19
Kunming 14
Redwood City 14
Mountain View 13
Munich 13
Des Moines 11
Jinan 11
Guangzhou 10
Regensburg 9
Shanghai 9
Athens 8
Nürnberg 8
Philadelphia 8
Redmond 8
San Diego 8
Camerino 7
Detroit 7
San Mateo 7
Catania 6
Palermo 6
Ardabil 5
Auburn Hills 5
Chongqing 5
Hanoi 5
Kharkiv 5
Los Angeles 5
Padova 5
Perugia 5
Phoenix 5
Tappahannock 5
Basel 4
Chieti 4
Fuzhou 4
Grafing 4
Hebei 4
Nanchang 4
Shenyang 4
Stockholm 4
Stony Brook 4
Taipei 4
Trieste 4
Wuhan 4
Abbiategrasso 3
Acerra 3
Alcobendas 3
Borovan 3
Buffalo 3
Carignano 3
Chengdu 3
Ferrara 3
Helsinki 3
Lappeenranta 3
Monmouth Junction 3
Montréal 3
Recanati 3
Reggio Nell'emilia 3
Saint Petersburg 3
Singapore 3
Varallo 3
Vicenza 3
Totale 6.763
Salva come PNG Salva come JPEG
Nome #
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 352
Regulation of expression of PI3Kbeta protein in tumors 250
Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development 229
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 200
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 187
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters 154
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice 131
Activation of T cells against HER-2/neu+ by autologous dendritic cells loaded with rat HER-2/neu+ cells in the presence of CCL16 119
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway 114
Effective anti-tumor immunomodulatory properties of zoledronic acid 114
Immunotherapy and immunoprevention of cancer: where do we stand? 109
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 106
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 105
Activation of T cells against human HER-2/neu by autologous Dendritic Cells loaded with rat HER-2/neu+ cells in the presence of CCL16 104
Immunological inhibition of carcinogenesis 103
Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. 101
A role for WASP Interacting Protein, WIP, in fibroblast adhesion, spreading and migration 99
Le difese immunitarie. 99
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins 94
Paramagnetic metal complexes for the MRI visualization of internalized polynucleotides 93
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions 93
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity 92
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. 92
2011: the immune hallmarks of cancer. 90
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity 88
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy. 87
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 85
A better immune reaction to Erbb-2 85
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention 85
Towards a long-lasting immune prevention of HER2 mammary carcinomas: directions from transgenic mice 84
Anaplastic Lymphoma Kinase is an effective oncoantigen for lymphoma vaccination 83
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination 83
Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha 82
Vaccination to kitL: a new approach to inhibit tumor angiogenesis 81
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice 81
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 80
Antitumor vaccines genetically engineered with cytokine gens 80
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy 79
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene 78
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. 78
A tumour-associated membrane antigen transiently expressed by normal cells during mitosis. 77
Valutazione preclinica di un nuovo approccio terapeutico: la vaccinazione a DNA protegge dal carcinoma sqaumoso orale chimicamente indotto 77
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. 77
Distribution of interferon-gamma receptor in human tissues. 76
DNA vaccination against Her-2 by electroporation protects rodents against squamous cell carcinomas 76
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. 76
p130Cas is an essential transducer element in ErbB2 transformation 76
Cure of Mammary Carcinomas in Her-2 Transgenic Mice Through Sequential Stimulation of Innate (neo-adjuvant IL12) and Adaptive (DNA Vaccine Electroporation) Immunity 76
Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukaemic cells. 76
Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas 75
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 75
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 75
p185neu-Encoding DNA and therapeutical uses thereof 74
Zoledronic acid impairs mammary carcinogenesis in BALB/c mice transgenic for the Her-2/neu oncogene. 74
Visualization through magnetic resonance imaging of DNA internalized following "in vivo" electroporation 73
COSTRUTTO DI ACIDO NUCLEICO, VETTORE E VACCINO A DNA INCLUDENTI DETTO COSTRUTTO 73
Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts. 72
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice 71
Dendritic cells transfected with DNA encoding ErbB2 rat/human chimeric plasmids are able to activate in vitro a specific T cell response in ErbB2+ cancer patients 71
Human lymphocyte activation requires IFN-γ-mediated signals. 70
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 70
Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells. 69
Lactoferrin, a Major Defense Protein of innate immunity, is a novel maturation factor for human dendritic cells 69
Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. 68
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 68
Effective anti-tumor immunomodulatory properties of zoledronic acid in Balb/c mice transgenic for the her-2/Neu oncogene 68
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer prone transgenic mice 67
DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma 67
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene–dependent breast tumorigenesis 66
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx 66
Are oncoantigens suitable targets for anti-tumour therapy? 66
Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells 65
Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes 64
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 64
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy 64
Evidence for a membrane carrier molecule common to embryonal and tumour-specific antigenic determinants expressed by a mouse transplantable tumour. 63
Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations. 63
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 63
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth 62
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice 62
Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. 61
L'INTERAZIONE TRA INTERFERONE GAMMA E IL SUO RECETTORE COSTITUISCE UN SEGNALE AUTOCRINO INDISPENSABILE PER L'INDUZIONE DELLA RISPOSTA IMMUNITARIA 61
TUMORI 60
Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice 60
Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice 59
CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity 59
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. 59
Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice 58
DNA vaccination against ERBB2 oncoantigen impairs oral tumor development 58
Immunization in tumor prevention. 58
DNA codificante p185neu e suoi usi terapeutici 58
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 58
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles (VLPs) prevents outgrowth of Her2/neu expressing tumors 57
Molecular basis of the immunogenicity of cell surface tumor antigens. 56
Trichomonas vaginalis: dependence of resistance among different mouse strains upon the non-H-2 gene haplotype, sex, and age of recipient hosts. 56
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 54
Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes 54
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 54
Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation. 53
Death receptor ligands in tumors. 53
Totale 8.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.173
article - articoli 0
book - libri 0
conference - conferenze 3.050
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019296 0 0 0 0 0 0 0 0 0 55 188 53
2019/20201.885 63 102 174 158 173 299 222 83 233 143 124 111
2020/20211.283 126 56 141 44 119 40 139 30 241 107 86 154
2021/20221.514 33 35 46 108 60 38 148 78 65 125 304 474
2022/20232.662 305 180 35 285 259 731 194 165 300 54 104 50
2023/2024642 133 155 50 32 46 151 28 36 0 11 0 0
Totale 12.297